Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...

SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation ...

The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...

A Pickerington high school basketball coach is recovering at home after receiving a kidney donation. Coach Leon Chou first ...

Minimally invasive surgery linked to lower major complication risk, reduced length of stay, decreased transfusion rate.

Investing in emerging biotechnology stocks can be a high-risk, high-reward scenario, with the three stocks we’re looking at a ...

Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs.

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) ('Crinetics”), a pharmaceutical company focused on the discovery, development ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 ...